fda semaglutide shortage resolved feb 21 2025 As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A US judge upholds FDA's removal

No study has reported extension of mammalian life with NAC-alone and, on the contrary, supplementing NAC-alone in C

The core of this litigation targets major pharmaceutical companies, Novo Nordisk and Eli Lilly and Co., accusing them of failing to sufficiently warn users about the severe digestive side effects of GLP-1 class drugs, typically prescribed for diabetes management and weight loss

Optimal Man Optimal Man was designed for men ages 20 and up who want to optimize the DNA passed to their future children

Can the reconstituted Semaglutide GLP-1 solution be frozen

Studies examining neurodegenerative disease models demonstrate BPC-157's protective effects in cuprizone-induced demyelination (a multiple sclerosis model) and other neurodegenerative conditions